Fuad El-Hibri
Executive Chairman of the Board of Directors Fuad El-Hibri
Executive Chairman of the Board of Directors
Mr. El-Hibri is the founder and executive chairman of the board of Emergent BioSolutions Inc. He served as Emergent’s chief executive officer since its inception in September 1998 until March 2012. His career in life sciences began in the early 90s with Porton Products, Ltd., a private biotechnology company in the U.K. Mr. El-Hibri organized and co-directed a management buyout of Porton and formed Speywood Holdings, Ltd., a recapitalized biopharmaceutical company with marketed biologics pr... |
|
 |
Daniel J. Abdun-Nabi
President and Chief Executive Officer Daniel J. Abdun-Nabi
President and Chief Executive Officer
Mr. Abdun-Nabi has served as chief executive officer since April 2012, as president since March 2007, and as a board member since May 2009. He previously served as chief operating officer from May 2007 through March 2012. Mr. Abdun-Nabi served as senior vice president corporate affairs and general counsel from December 2004 to April 2007, secretary from December 2004 to January 2008, and vice president and general counsel from May 2004 to December 2004. Prior to joining the company, Mr. ... |
|
|
Steven N. Chatfield, Ph.D.
Executive Vice President, Strategic Investments Division Steven N. Chatfield, Ph.D.
Executive Vice President, Strategic Investments Division
Dr. Chatfield has served as executive vice president, Strategic Investments Division since April 1, 2013. Previously, he served as executive vice president and president, BioSciences Division since December 2011. He served as chief business officer and senior vice president strategic investments from May 2011 until December 2011. Dr. Chatfield served as senior vice president strategic investments from March 2010 to May 2011 and senior vice president biodefense from December 2009 to March 2010. P... |
|
|
Adam R. Havey
Executive Vice President and President, BioDefense Division Adam R. Havey
Executive Vice President and President, BioDefense Division
Mr. Havey has served as executive vice president and president, BioDefense Division since December 2011, and as executive vice president BioDefenseDivision since March 2011. He previously served as president of Emergent BioDefense Operations Lansing from January 2009 to February 2011 and vice president of business operations from November 2007 to December 2008. Mr. Havey previously served as senior director manufacturing development from June 2006 to November 2007, as director, facilities, resou... |
|
|
W. James Jackson, Ph.D.
Senior Vice President and Chief Scientific Officer W. James Jackson, Ph.D.
Senior Vice President and Chief Scientific Officer
Dr. Jackson has served as senior vice president and chief scientific officer since February 2008. Dr. Jackson served as vice president technical support from June 2007 to February 2008 and vice president commercial development from April 2005 to June 2007. Prior to joining the company, Dr. Jackson served as president, Antex Biologics Research and Development Corporation from January 2004 to May 2005. Dr. Jackson served in various research and development positions at Antex Biologics Inc, a biote... |
|
|
Robert G. Kramer
Executive Vice President, Corporate Services Division, Chief Financial Officer, Treasurer Robert G. Kramer
Executive Vice President, Corporate Services Division, Chief Financial Officer, Treasurer
Mr. Kramer has served as CFO since December 2012, and as executive vice president, corporate services division since September 2012. He is responsible for finance, legal affairs, strategic investments, human capital, management services and sales and marketing. Mr. Kramer first joined Emergent in 1999 as its Chief Financial Officer. From 1999 until his retirement in 2010, he held various executive positions with the last being president of Emergent BioDefense Operations Lansing. Mr. Kramer retur... |
|
|
Denise Landry
Senior Vice President and Chief Quality Officer Denise Landry
Senior Vice President and Chief Quality Officer
Ms. Landry has served as senior vice president and chief quality officer since March 2011. Ms. Landry served as senior vice president quality, regulatory and medical affairs from February 2010 to March 2011, senior vice president quality and regulatory affairs from January 2008 to February 2010, and as senior vice president quality from October 2007 to January 2008. Prior to joining the company, Ms. Landry served as vice president corporate quality for Guilford Pharmaceuticals and its successor ... |
|
|
Paula M. Lazarich
Senior Vice President Human Capital Paula M. Lazarich
Senior Vice President Human Capital
Ms. Lazarich has served as senior vice president human capital since March 2011. Ms. Lazarich served as vice president human resources from November 2005 to March 2011. Prior to joining the company, Ms. Lazarich served as vice president human resources for Cardinal Health from 1999 to 2005. Ms. Lazarich served as director human resources for The Mcgraw-Hill Companies from 1993 to 1999, for Datapro Information Services from 1993 to 1996, and for Freedom River, Inc d.b.a. Budget Rent a Car from 19... |
|
|
Allen Shofe
Executive Vice President, Corporate Affairs Division Allen Shofe
Executive Vice President, Corporate Affairs Division
Mr. Shofe has served as executive vice president, Corporate Affairs Division since April 1, 2013. Previously, he served as senior vice president corporate affairs since August 2010. Mr. Shofe served as senior vice president public affairs from January 2008 to August 2010, vice president public affairs from May 2007 to January 2008, and vice president government affairs from 2005 to 2007. Prior to joining the company, Mr. Shofe served as director, federal government affairs for Eli Lil... |
|
|
Scott C. Stromatt, M.D.
Senior Vice President and Chief Medical Officer Scott C. Stromatt, M.D.
Senior Vice President and Chief Medical Officer
Dr. Stromatt has served as senior vice president, clinical and chief medical officer since October 2010. Prior to the acquisition of Trubion by Emergent BioSolutions, Dr. Stromatt served as senior vice president and chief medical officer of Trubion since August 2008. Dr. Stromatt was an employee of Cell Therapeutics from January 2003 to April 2008 where he last served as executive vice president clinical development and regulatory affairs. Dr. Stromatt was vice president of clinical research and... |
|
|
